BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant 2018;53:138-45. [PMID: 28759025 DOI: 10.1038/bmt.2017.161] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Akazawa R, Kato I, Kubota H, Isobe K, Masuno H, Mikami M, Shiota M, Kouzuki K, Kawabata N, Tanaka K, Saida S, Umeda K, Hiramatsu H, Adachi S, Takita J. Inotuzumabozogamicin is an effective treatment for CD22-positive acute undifferentiated leukemia: A case report. Pediatr Blood Cancer 2021;68:e28976. [PMID: 33619873 DOI: 10.1002/pbc.28976] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cesaro S, Mauro M, Sattin G, Sartori MT, Saggiorato G, Paratella A, Tridello G, Bisogno G. PAI-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor. Pediatr Blood Cancer 2019;66:e27695. [PMID: 30865371 DOI: 10.1002/pbc.27695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Embaby MM, Rangarajan HG, Abu-Arja R, Auletta JJ, Stanek J, Pai V, Nicol KK, Bajwa RS. Refractory Thrombocytopenia Is a Valid Early Diagnostic Criteria for Hepatic Veno-Occlusive Disease in Children. Biol Blood Marrow Transplant 2020;26:546-52. [PMID: 31756537 DOI: 10.1016/j.bbmt.2019.11.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Gurlek Gokcebay D, Arman Bilir O, Şahin S, Ok Bozkaya İ, Ozbek NY. Role of therapeutic drug monitoring of intravenous Busulfan for prevention of sinusoidal obstructive syndrome in children. Pediatr Transplant 2022;:e14266. [PMID: 35343635 DOI: 10.1111/petr.14266] [Reference Citation Analysis]
5 Zama D, Muratore E, Biagi E, Forchielli ML, Rondelli R, Candela M, Prete A, Pession A, Masetti R. Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections. Nutr J 2020;19:29. [PMID: 32276595 DOI: 10.1186/s12937-020-00537-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lee AC, Aung L. Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine. Pediatr Blood Cancer 2019;66:e27518. [PMID: 30350914 DOI: 10.1002/pbc.27518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lia G, Giaccone L, Leone S, Bruno B. Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role? Front Immunol 2021;12:641427. [PMID: 34093530 DOI: 10.3389/fimmu.2021.641427] [Reference Citation Analysis]
8 Stanulla M, Schaeffeler E, Möricke A, Buchmann S, Zimmermann M, Igel S, Schmiegelow K, Flotho C, Hartmann H, Illsinger S, Sauerbrey A, Junk SV, Schütte P, Hinze L, Lauten M, Modlich S, Kolb R, Rossig C, Schwabe G, Gnekow AK, Fleischhack G, Schlegel PG, Schünemann HJ, Kratz CP, Cario G, Schrappe M, Schwab M. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia. Leukemia 2021;35:2650-7. [PMID: 33714975 DOI: 10.1038/s41375-021-01203-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Calbi V, Fumagalli F, Consiglieri G, Penati R, Acquati S, Redaelli D, Attanasio V, Marcella F, Cicalese MP, Migliavacca M, Barzaghi F, Ferrua F, Assanelli A, Silvani P, Zoccolillo M, Chidini G, Chiesa R, Arora R, Ciotti F, Sarzana M, Antonioli G, Baldoli C, Morena F, Martino S, Ardissino GL, Sora MGN, Naldini L, Ciceri F, Aiuti A, Bernardo ME. Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy. Bone Marrow Transplant 2018;53:913-7. [PMID: 29379168 DOI: 10.1038/s41409-017-0085-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Trenker C, Dietrich CF, Klein S, Safai Zadeh E, Sohlbach K, Neubauer A, Burchert A, Görg C. [Potential of ultrasound in allogeneic stem cell transplantation and transplant-related complications]. Z Gastroenterol 2021;59:336-44. [PMID: 33634439 DOI: 10.1055/a-1374-4192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Richardson PG, Grupp SA, Pagliuca A, Krishnan A, Ho VT, Corbacioglu S. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure. Int J Hematol Oncol 2017;6:75-93. [PMID: 30302228 DOI: 10.2217/ijh-2017-0015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
12 Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, Cavo M, Colecchia A. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2020;11:489. [PMID: 32318059 DOI: 10.3389/fimmu.2020.00489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
13 Ebbesen M, Kissow H, Hartmann B, Kielsen K, Sørensen K, Stinson SE, Frithioff-Bøjsøe C, Esmann Fonvig C, Holm JC, Hansen T, Holst JJ, Müller KG. Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:793588. [PMID: 34956226 DOI: 10.3389/fimmu.2021.793588] [Reference Citation Analysis]
14 Corbacioglu S, Jabbour EJ, Mohty M. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biology of Blood and Marrow Transplantation 2019;25:1271-80. [DOI: 10.1016/j.bbmt.2019.02.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
15 Essa MF, Abujoub R, Elbashir E, Alsudairy R, Alomari A, Alsultan A. HLA-matched HSCT using targeted busulfan-based conditioning in children with primary hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2021;56:3097-9. [PMID: 34593985 DOI: 10.1038/s41409-021-01468-7] [Reference Citation Analysis]
16 Cortes JE, de Lima M, Dombret H, Estey EH, Giralt SA, Montesinos P, Röllig C, Venditti A, Wang ES. Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia. J Hematol Oncol 2020;13:137. [PMID: 33059764 DOI: 10.1186/s13045-020-00975-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Peng C, Zhang X, Zhang F, Liu L, Shao Y, Xiang X, Zhang W, Xiao J, Wang Y, Zhang B, Yin Q, Song Y, Mo Z, Zou X, Zhang M, Zhuge Y. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study. European Journal of Gastroenterology & Hepatology 2020;32:1168-78. [DOI: 10.1097/meg.0000000000001630] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
18 Zama D, Bossù G, Ravaioli F, Masetti R, Prete A, Festi D, Pession A. Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease. Pediatr Transplant 2019;23:e13456. [PMID: 31081161 DOI: 10.1111/petr.13456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Corbacioglu S, Topaloglu O, Aggarwal S. A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Clin Drug Investig 2022. [PMID: 35594010 DOI: 10.1007/s40261-022-01140-y] [Reference Citation Analysis]
20 Golay H, Jurkovic Mlakar S, Mlakar V, Nava T, Ansari M. The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review. Int J Mol Sci 2019;20:E3889. [PMID: 31404983 DOI: 10.3390/ijms20163889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Calvo C, Cabannes‐hamy A, Adjaoud D, Bruno B, Blanc L, Boissel N, Tabone M, Willson‐plat G, Villemonteix J, Baruchel A, Brethon B. Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22 ‐positive B‐cell acute lymphoblastic leukaemia. Br J Haematol 2020;190. [DOI: 10.1111/bjh.16732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Gavriilaki E, Ho VT, Schwaeble W, Dudler T, Daha M, Fujita T, Jodele S. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy. Exp Hematol Oncol 2021;10:57. [PMID: 34924021 DOI: 10.1186/s40164-021-00249-8] [Reference Citation Analysis]
23 Apsel Winger B, Shukla P, Kharbanda S, Keizer RJ, Goswami S, Cowan MJ, Dvorak CC, Long-Boyle J. The Relationship Between Busulfan Exposure and Achievement of Sustained Donor Myeloid Chimerism in Patients with Non-Malignant Disorders. Transplant Cell Ther 2021;27:258.e1-6. [PMID: 33781528 DOI: 10.1016/j.jtct.2020.12.005] [Reference Citation Analysis]
24 Maximova N, Granzotto M, Barbieri F, Marcuzzi A, Tommasini A, Monasta L, Simeone R, Zanon D, Sala R. Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients. Cancer Med 2019;8:890-901. [PMID: 30690926 DOI: 10.1002/cam4.1912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Colecchia A, Ravaioli F, Sessa M, Alemanni VL, Dajti E, Marasco G, Vestito A, Zagari RM, Barbato F, Arpinati M, Cavo M, Festi D, Bonifazi F. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study. Biol Blood Marrow Transplant. 2019;25:995-1003. [PMID: 30660772 DOI: 10.1016/j.bbmt.2019.01.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
26 Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation. Br J Haematol 2020;190:822-36. [PMID: 32133623 DOI: 10.1111/bjh.16557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
27 Dvorak CC, Long-Boyle J, Dara J, Melton A, Shimano KA, Huang JN, Puck JM, Dorsey MJ, Facchino J, Chang CK, Cowan MJ. Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency. Biol Blood Marrow Transplant 2019;25:1355-62. [PMID: 30876930 DOI: 10.1016/j.bbmt.2019.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
28 Faraci M, Bertaina A, Luksch R, Calore E, Lanino E, Saglio F, Prete A, Menconi M, De Simone G, Tintori V, Cesaro S, Santarone S, Orofino MG, Locatelli F, Zecca M. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group. Biol Blood Marrow Transplant 2019;25:313-20. [PMID: 30266674 DOI: 10.1016/j.bbmt.2018.09.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
29 Kurzay M, Hauck F, Schmid I, Wiebking V, Eichinger A, Jung E, Boekstegers A, Feuchtinger T, Klein C, Albert MH. T-cell replete haploidentical bone marrow transplantation and post-transplant cyclophosphamide for patients with inborn errors. Haematologica 2019;104:e478-82. [PMID: 30846493 DOI: 10.3324/haematol.2018.215285] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
30 Alsalamah S, Alramyan R, Alakel R, Altheyeb F, Alrashed R, Masuadi E, Alyousif G, Bin Sunaid FF, Alsultan A, Essa MF. The outcome and complications of total parenteral nutrition in pediatric hematopoietic stem cell transplantation. Pediatr Transplant 2021;:e14198. [PMID: 34811859 DOI: 10.1111/petr.14198] [Reference Citation Analysis]
31 Waespe N, Strebel S, Jurkovic Mlakar S, Krajinovic M, Kuehni CE, Nava T, Ansari M. Genetic Predictors for Sinusoidal Obstruction Syndrome-A Systematic Review. J Pers Med 2021;11:347. [PMID: 33925809 DOI: 10.3390/jpm11050347] [Reference Citation Analysis]
32 Chan SS, Colecchia A, Duarte RF, Bonifazi F, Ravaioli F, Bourhis JH. Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biol Blood Marrow Transplant 2020;26:1770-9. [PMID: 32593647 DOI: 10.1016/j.bbmt.2020.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Dvorak CC, Higham C, Shimano KA. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management. Front Pediatr 2019;7:133. [PMID: 31024873 DOI: 10.3389/fped.2019.00133] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
34 Özkan SG, Özkan HA. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: diagnosis, incidence, prophylaxis, and treatment. Transfusion and Apheresis Science 2022. [DOI: 10.1016/j.transci.2022.103372] [Reference Citation Analysis]
35 Shang H, Bai T, Zhu S, Yang X, Liu C, Xu D, Zhuge Y, Song Y, Hou X. Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China. Ann Transl Med 2021;9:11. [PMID: 33553304 DOI: 10.21037/atm-20-731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Zhang Y, Yan Y, Song B. Noninvasive imaging diagnosis of sinusoidal obstruction syndrome: a pictorial review. Insights Imaging 2019;10:110. [PMID: 31748956 DOI: 10.1186/s13244-019-0791-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
37 Botti S, Agreiter I, Orlando L, Gargiulo G, Bonifazi F, Banfi MM, Cappucciati L, Caffarri C, De Cecco V, Deiana GM, Gavezzotti M, Magarò A, Netti MG, Pignatelli AC, Rostagno E, Samarani E, Cardoso JS, Soave S, Valente CM, Vedovetto A, Zecca M, Luminari S, Merli F, Guberti M. Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the "Gruppo Italiano Trapianto di Midollo Osseo". Support Care Cancer 2020;28:5125-37. [PMID: 32056012 DOI: 10.1007/s00520-020-05353-9] [Reference Citation Analysis]
38 Putra J, Ng VL, Perez-Atayde AR. Pediatric Acute Liver Failure: A Clinicopathological Perspective. Pediatr Dev Pathol 2022;:10935266211067893. [PMID: 35356839 DOI: 10.1177/10935266211067893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Mohty M, Battista ML, Blaise D, Calore E, Cesaro S, Maximova N, Perruccio K, Renard C, Wynn R, Zecca M, Labopin M, Hanvesakul R, Amber V, Ryan RJ, Lawson S, Ciceri F. A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplant 2021. [PMID: 34059801 DOI: 10.1038/s41409-021-01265-2] [Reference Citation Analysis]
40 Shukla P, Dvorak CC, Long-Boyle J, Kharbanda S. Lower Exposure to Busulfan Allows for Stable Engraftment of Donor Hematopoietic Stem Cells in Children with Mucopolysaccharidosis Type I: A Case Report of Four Patients. Int J Mol Sci 2020;21:E5634. [PMID: 32781600 DOI: 10.3390/ijms21165634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Chung H, Im SA, Kim SK. Ultrasound in Hepatic Veno-occlusive Disease (HVOD) after Pediatric Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Diagnostic Criteria Including the Pediatric Criteria of European Society for Blood and Marrow Transplantation (EBMT). Pediatr Hematol Oncol 2020;37:275-87. [PMID: 32131664 DOI: 10.1080/08880018.2020.1725199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Corbacioglu S, Kernan NA, Pagliuca A, Ryan RJ, Tappe W, Richardson PG. Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients. Biol Blood Marrow Transplant 2020;26:1342-9. [PMID: 32200121 DOI: 10.1016/j.bbmt.2020.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Duncan C, Kahn J, Grupp SA, Richardson PG. Recent developments with defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert Opinion on Orphan Drugs 2019;7:337-47. [DOI: 10.1080/21678707.2019.1651641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Ansari M, Petrykey K, Rezgui MA, Del Vecchio V, Cortyl J, Ralph RO, Nava T, Beaulieu P, St-Onge P, Jurkovic Mlakar S, Huezo-Diaz Curtis P, Uppugunduri CRS, Lesne L, Théoret Y, Chalandon Y, Bartelink IH, Boelens JJ, Bredius RGM, Dalle JH, Lewis V, Kangarloo BS, Peters C, Sinnett D, Bittencourt H, Krajinovic M; Pediatric Disease Working Party of the European Society for Blood and Marrow Transplantation. Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:920-7. [PMID: 31790828 DOI: 10.1016/j.bbmt.2019.11.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
45 Kammersgaard MB, Kielsen K, Heilmann C, Ifversen M, Müller K. Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome. Bone Marrow Transplant 2019;54:1406-18. [PMID: 30683907 DOI: 10.1038/s41409-018-0426-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Richardson PG, Triplett BM, Ho VT, Chao N, Dignan FL, Maglio M, Mohty M. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert Rev Clin Pharmacol. 2018;11:113-124. [PMID: 29301447 DOI: 10.1080/17512433.2018.1421943] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
47 Karagun BS, Akbas T, Erbey F, Sasmaz İ, Antmen B. The Prophylaxis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome With Defibrotide After Hematopoietic Stem Cell Transplantation in Children: Single Center Experience. J Pediatr Hematol Oncol 2022;44:e35-9. [PMID: 34966102 DOI: 10.1097/MPH.0000000000002379] [Reference Citation Analysis]
48 Cabanillas Stanchi KM, Queudeville M, Malaval C, Feucht J, Schlegel P, Dobratz M, Seitz C, Müller I, Lang P, Handgretinger R, Döring M. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients. J Cancer Res Clin Oncol 2019;145:2779-91. [PMID: 31446489 DOI: 10.1007/s00432-019-03008-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Kernan NA, Richardson PG, Smith AR, Triplett BM, Antin JH, Lehmann L, Messinger Y, Liang W, Hume R, Tappe W, Soiffer RJ, Grupp SA. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program. Pediatr Blood Cancer 2018;65:e27269. [PMID: 29873895 DOI: 10.1002/pbc.27269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
50 Carcedo Rodriguez D, Artola Urain T, Chinea Rodriguez A, García Torres E, González Vicent M, Gutiérrez García G, Regueiro García A, Calvo Hidalgo M, Villacampa A. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain. J Med Econ 2021;24:628-36. [PMID: 33858278 DOI: 10.1080/13696998.2021.1916749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Rajagopal R, Phillips MB, Gottardo NG. "Pre-emptive strike"-the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide. Pediatr Blood Cancer 2018;65:e27036. [PMID: 29537138 DOI: 10.1002/pbc.27036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Dhir A, Wadhwa A, Haines H, Chewning J, Murthy S, Kim J, Beatty L, Mixon E, Fowler KB, Gage J, Meadows T, Goldman F. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort. J Pediatr Hematol Oncol 2022;44:e343-8. [PMID: 35200220 DOI: 10.1097/MPH.0000000000002267] [Reference Citation Analysis]
53 Pawlik-Gwozdecka D, Irga-Jaworska N, Tomaszewski M, Adamkiewicz-Drożyńska E. Sinusoidal obstruction syndrome in a paediatric patient with acute lymphoblastic leukaemia after completion of reinduction therapy according to ALL Intercontinental Berlin-Frankfurt-Münster 2009. Contemp Oncol (Pozn) 2018;22:266-9. [PMID: 30783392 DOI: 10.5114/wo.2018.82646] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Szmit Z, Gorczynska E, Król A, Ussowicz M, Mielcarek-Siedziuk M, Olejnik I, Panasiuk A, Kałwak K. Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? : Prospective evaluation of pediatric EBMT criteria for VOD. Bone Marrow Transplant 2020;55:2138-46. [PMID: 32398785 DOI: 10.1038/s41409-020-0918-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Felber M, Steward CG, Kentouche K, Fasth A, Wynn RF, Zeilhofer U, Haunerdinger V, Volkmer B, Prader S, Gruhn B, Ehl S, Lehmberg K, Müller D, Gennery AR, Albert MH, Hauck F, Rao K, Veys P, Hassan M, Lankester AC, Schmid JP, Hauri-Hohl MM, Güngör T. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv 2020;4:1998-2010. [PMID: 32384542 DOI: 10.1182/bloodadvances.2020001748] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
56 Hecht A, Meyer J, Chehab FF, White KL, Magruder K, Dvorak CC, Loh ML, Stieglitz E. Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia. Pediatr Blood Cancer 2019;66:e27948. [PMID: 31347788 DOI: 10.1002/pbc.27948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Roh YY, Hahn SM, Kim HS, Ahn WK, Han JH, Kwon S, Lyu CJ, Han JW. Efficacy of low dose and short duration defibrotide prophylaxis for hepatic veno-occlusive disease after autologous haematopoietic stem cell transplantation. Bone Marrow Transplant 2021;56:411-8. [PMID: 32839533 DOI: 10.1038/s41409-020-01036-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Roeker LE, Kim HT, Glotzbecker B, Nageshwar P, Nikiforow S, Koreth J, Armand P, Cutler C, Alyea EP, Antin JH, Richardson PG, Soiffer RJ, Ho VT. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2019;25:137-44. [DOI: 10.1016/j.bbmt.2018.07.039] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
59 Schlaweck S, Bauer CJ, Schmitz F, Brossart P, Holderried TAW, Schäfer VS. Preliminary Report for the Development of a Multiparameter Protocol for the Identification of Sinusoidal Obstruction Syndrome including Abdominal Ultrasound before and after Allogeneic Stem Cell Transplantation. Applied Sciences 2022;12:829. [DOI: 10.3390/app12020829] [Reference Citation Analysis]
60 Akıncı B, Atay D, Demir Yenigürbüz F, Akçay A, Öztürk G. Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Exp Clin Transplant 2022. [PMID: 35607801 DOI: 10.6002/ect.2021.0475] [Reference Citation Analysis]
61 El-Serafi I, Remberger M, Ringdèn O, Törlén J, Sundin M, Björklund A, Winiarski J, Mattsson J. Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation. Clin Transl Sci 2020;13:293-300. [PMID: 31675173 DOI: 10.1111/cts.12709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Richardson P, Aggarwal S, Topaloglu O, Villa KF, Corbacioglu S. Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS). Bone Marrow Transplant 2019;54:1951-62. [PMID: 30804485 DOI: 10.1038/s41409-019-0474-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
63 Yamamoto S, Toyama D, Sugishita Y, Kaneko R, Okamoto N, Koganesawa M, Fujita S, Akiyama K, Matsuno R, Isoyama K. Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants. Pediatr Transplant 2018;22:e13269. [PMID: 30003636 DOI: 10.1111/petr.13269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Kong SG, Lee JH, Lim YT, Lee JH, Eom HS, Lee H, Kim DY, Lim SN, Yoon SS, Kim SY, Lee HS. Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide. Korean J Intern Med 2021. [PMID: 34902236 DOI: 10.3904/kjim.2021.178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Lee C, Chang H, Lu M, Yang Y, Chou S, Lin D, Jou S, Yao M, Li C, Yeh S, Chen M, Gau J, Li S, Wang P, Liu Y, Wang T, Tan T, Lee M, Yu M, Wang C, Lin S, Chen Y, Su Y, Su K, Lin K. The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan. Ann Hematol 2019;98:745-52. [DOI: 10.1007/s00277-019-03604-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
66 Bohte AE, Dierselhuis MP, van Noesel MM, Lequin MH. Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children. Pediatr Radiol 2021. [PMID: 34729635 DOI: 10.1007/s00247-021-05174-w] [Reference Citation Analysis]
67 Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv 2018;2:1495-509. [PMID: 29945939 DOI: 10.1182/bloodadvances.2017008375] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
68 Leimi L, Jahnukainen K, Olkinuora H, Meri S, Vettenranta K. Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2022. [PMID: 35177827 DOI: 10.1038/s41409-022-01607-8] [Reference Citation Analysis]
69 Ichimura K, Kawamura N, Goto R, Watanabe M, Ganchiku Y, Shimamura T, Taketomi A, Grenda R. Living Donor Liver Transplantation for Hepatic Venoocclusive Disease/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell Transplantation. Case Reports in Transplantation 2022;2022:1-6. [DOI: 10.1155/2022/8361769] [Reference Citation Analysis]
70 Duncan C, St Martin A, Pérez WS, Steinert P, Zhang MJ, Chirnomas D, Hoang CJ, Loberiza FR Jr, Saber W. Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer 2021;68:e29067. [PMID: 33871892 DOI: 10.1002/pbc.29067] [Reference Citation Analysis]
71 Robin S, Hassine KB, Muthukumaran J, Jurkovic Mlakar S, Krajinovic M, Nava T, Uppugunduri CRS, Ansari M. A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation. BMC Mol and Cell Biol 2022;23. [DOI: 10.1186/s12860-021-00402-5] [Reference Citation Analysis]
72 Eftychidis I, Sakellari I, Anagnostopoulos A, Gavriilaki E. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis. Expert Rev Hematol 2021. [PMID: 34388057 DOI: 10.1080/17474086.2021.1968823] [Reference Citation Analysis]
73 Bhunia N, Yeager ND, Colace SI, Buzzaco D, Bajwa RPS. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification. Pediatr Transplant 2020;24:e13638. [PMID: 31840375 DOI: 10.1111/petr.13638] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 González Vicent M, Díaz de Heredia C, González de Pablo J, Molina B, Regueiro A, Pérez Martinez A, Palomo P, López Corral L, García E, Fernández JM, Pérez A, Jiménez MJ, Guerreiro M, Vallejo C, Gallardo AI, López O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Jiménez Ubieto A, González P, Gómez Centurión I, Costilla L, Beléndez C, Esquirol A, Espigado I, Lavilla E, Díaz MÁ. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH). Eur J Haematol 2021;106:842-50. [PMID: 33713387 DOI: 10.1111/ejh.13618] [Reference Citation Analysis]
75 Masetti R, Biagi E, Zama D, Muratore E, D'Amico F, Leardini D, Turroni S, Prete A, Brigidi P, Pession A. Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Sci Rep 2021;11:14307. [PMID: 34253759 DOI: 10.1038/s41598-021-93571-4] [Reference Citation Analysis]
76 Penel-Page M, Plesa A, Girard S, Marceau-Renaut A, Renard C, Bertrand Y. Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience. Pediatr Blood Cancer 2020;67:e28305. [PMID: 32307866 DOI: 10.1002/pbc.28305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
77 Higham CS, Shimano KA, Melton A, Kharbanda S, Chu J, Dara J, Winestone LE, Hermiston ML, Huang JN, Dvorak CC. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients. Pediatr Blood Cancer 2022;69:e29641. [PMID: 35253361 DOI: 10.1002/pbc.29641] [Reference Citation Analysis]
78 Hildebrandt GC, Chao N. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation. Br J Haematol 2020;190:508-19. [PMID: 32319084 DOI: 10.1111/bjh.16621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
79 Ruutu T, Carreras E. Hepatic Complications. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 373-9. [DOI: 10.1007/978-3-030-02278-5_49] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
80 Maximova N, Caddeo G, Zanon D, Maestro A, Simeone R. Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients. J Clin Med 2019;8:E825. [PMID: 31185690 DOI: 10.3390/jcm8060825] [Reference Citation Analysis]
81 Betzmann D, Döring M, Blumenstock G, Erdmann F, Grabow D, Lang P, Binder G. Impact of serum insulin-like growth factor-1 on HSCT outcome in pediatric cancer patients. Transplant Cell Ther 2022:S2666-6367(22)01195-2. [PMID: 35405367 DOI: 10.1016/j.jtct.2022.03.027] [Reference Citation Analysis]
82 Lai X, Liu L, Zhang Z, Shi L, Yang G, Wu M, Huang R, Liu R, Lai Y, Li Q. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome. Bone Marrow Transplant 2021;56:1635-41. [PMID: 33608657 DOI: 10.1038/s41409-021-01233-w] [Reference Citation Analysis]
83 Zhou ZY, Tang W, Villa KF. Indirect costs associated with premature mortality among those with veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan dysfunction post-hematopoietic stem-cell-transplant. Clinicoecon Outcomes Res 2019;11:13-22. [PMID: 30588050 DOI: 10.2147/CEOR.S184883] [Reference Citation Analysis]
84 Lamble AJ, Tasian SK. Opportunities for immunotherapy in childhood acute myeloid leukemia. Blood Adv 2019;3:3750-8. [PMID: 31770440 DOI: 10.1182/bloodadvances.2019000357] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
85 Kaya N. Grayscale and Spectral Doppler Ultrasound in the Diagnosis of Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children. J Pediatr Hematol Oncol 2021. [PMID: 34654765 DOI: 10.1097/MPH.0000000000002334] [Reference Citation Analysis]
86 Dietrich CF, Trenker C, Fontanilla T, Görg C, Hausmann A, Klein S, Lassau N, Miquel R, Schreiber-Dietrich D, Dong Y. New Ultrasound Techniques Challenge the Diagnosis of Sinusoidal Obstruction Syndrome. Ultrasound Med Biol 2018;44:2171-82. [PMID: 30076031 DOI: 10.1016/j.ultrasmedbio.2018.06.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
87 Chan WYK, Ma ALT, Chan EYH, Kan ANC, Ng WF, Lee PPW, Cheuk DKL, Chiang AKS, Leung W, Chan GCF. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong. Pediatr Transplant 2022;:e14366. [PMID: 35860972 DOI: 10.1111/petr.14366] [Reference Citation Analysis]
88 Corbacioglu S, Richardson PG. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Expert Rev Gastroenterol Hepatol 2017;11:885-98. [PMID: 28825848 DOI: 10.1080/17474124.2017.1370372] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
89 Del Bufalo F, Merli P, Alessi I, Locatelli F. B-cell depleting immunotherapies: therapeutic opportunities and toxicities. Expert Rev Clin Immunol 2019;15:497-509. [PMID: 30681371 DOI: 10.1080/1744666X.2019.1573672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
90 Yoon JH, Choi CW, Won JH. Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea. Korean J Intern Med 2021;36:1261-80. [PMID: 34555279 DOI: 10.3904/kjim.2021.082] [Reference Citation Analysis]
91 Abate ME, Paioli A, Cammelli S, Cesari M, Longhi A, Palmerini E, Ferrari S, Carretta E, Picci P, Piscaglia F. Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma. Bone Marrow Transplant 2018;53:591-9. [PMID: 29335623 DOI: 10.1038/s41409-017-0066-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
92 Yoon J, Yoo KH, Sung KW, Jung CW, Kim JS, Hahn SM, Kang HJ, Lee J, Im HJ, Ahn J, Kook H, Cho B, Lee JW. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD). Bone Marrow Transplant 2019;54:1361-8. [DOI: 10.1038/s41409-019-0492-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
93 AlSaad T, Yousif T, Saleh A, Ahmed H, Cole C, Cugno C. Hepatic sinusoidal obstruction syndrome post-chemotherapy in pediatric and adolescent age: case series of six patients in Qatar. Ann Hematol 2021. [PMID: 33884455 DOI: 10.1007/s00277-021-04526-8] [Reference Citation Analysis]
94 Corbacioglu S. The coming of age of the pediatric EBMT criteria. Bone Marrow Transplant 2021;56:767-8. [PMID: 33221818 DOI: 10.1038/s41409-020-01141-5] [Reference Citation Analysis]
95 Manrai M, George E, Kapoor R. Profile of Hepatobiliary Dysfunction in Hematopoietic Stem Cell Transplant Recipients - An Indian Perspective. J Clin Exp Hepatol 2021;11:14-20. [PMID: 33679044 DOI: 10.1016/j.jceh.2020.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Contreras CF, Long-Boyle JR, Shimano KA, Melton A, Kharbanda S, Dara J, Higham C, Huang JN, Cowan MJ, Dvorak CC. Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants. Biol Blood Marrow Transplant 2020;26:1646-54. [PMID: 32534101 DOI: 10.1016/j.bbmt.2020.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
97 Corbacioglu S. Can We Improve Our Diagnostic Accuracy with Ultrasonography in Hepatic Veno-Occlusive Disease? Pediatr Hematol Oncol 2020;37:273-4. [PMID: 32270740 DOI: 10.1080/08880018.2020.1748352] [Reference Citation Analysis]
98 Kawashima N, Fukasawa Y, Nishikawa E, Ohta-Ogo K, Ishibashi-Ueda H, Hamada M, Ichikawa D, Narita A, Okuno Y, Muramatsu H, Nishio N, Kojima S, Kato T, Takahashi Y. Echocardiography Monitoring of Pulmonary Hypertension after Pediatric Hematopoietic Stem Cell Transplantation: Pediatric Pulmonary Arterial Hypertension and Pulmonary Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 2021;27:786.e1-8. [PMID: 34058426 DOI: 10.1016/j.jtct.2021.05.017] [Reference Citation Analysis]
99 Kohnken R, Falahatpisheh H, Janardhan KS, Guffroy M. Anatomic and Clinical Pathology Characterization of Drug-Induced Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in Cynomolgus Macaques. Toxicol Pathol 2021;:1926233211037932. [PMID: 34414838 DOI: 10.1177/01926233211037932] [Reference Citation Analysis]
100 Mahadeo KM, Bajwa R, Abdel-Azim H, Lehmann LE, Duncan C, Zantek N, Vittorio J, Angelo J, McArthur J, Schadler K, Chan S, Tewari P, Khazal S, Auletta JJ, Choi SW, Shoberu B, Kalwak K, Harden A, Kebriaei P, Abe JI, Li S, Moffet JR, Abraham S, Tambaro FP, Kleinschmidt K, Richardson PG, Corbacioglu S; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol 2020;7:e61-72. [PMID: 31818728 DOI: 10.1016/S2352-3026(19)30201-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
101 Wawrzyniak-Dzierżek E, Gajek K, Rybka B, Ryczan-Krawczyk R, Węcławek-Tompol J, Raciborska A, Mielcarek-Siedziuk M, Frączkiewicz J, Salamonowicz M, Kałwak K, Rosa M, Ślęzak A, Ussowicz M. Feasibility and Safety of Treosulfan, Melphalan, and Thiotepa-Based Megachemotherapy with Autologous or Allogeneic Stem Cell Transplantation in Heavily Pretreated Children with Relapsed or Refractory Neuroblastoma. Biol Blood Marrow Transplant 2019;25:1792-7. [PMID: 31085306 DOI: 10.1016/j.bbmt.2019.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Trenker C, Burchert A, Schumacher C, Schäfer JA, Dohse M, Timmesfeld N, Neubauer A, Sohlbach K, Michel C, Görg C. Pathologic Hepatic Contrast-Enhanced Ultrasound Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation. Ultrasound Med Biol 2020;46:1865-71. [PMID: 32499194 DOI: 10.1016/j.ultrasmedbio.2020.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
103 Xia Y, Qin H, Yang J. Hepatic veno-occlusive disease development in the hematopoietic stem cell transplantation patients: incidence and associated risk factors, a meta-analysis. Eur J Gastroenterol Hepatol 2021;33:872-84. [PMID: 32639417 DOI: 10.1097/MEG.0000000000001802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Raina R, Abu-arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, Mcculloch M, Menon S, Onder AM, Khooblall P, Khooblall A, Polishchuk V, Rangarajan H, Sultana A, Kashtan C. Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol. [DOI: 10.1007/s00467-022-05448-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Zirngibl F, Flemmig C, Lang P, Künkele A, Eggert A, Schulte JH, Deubzer HE. Sinusoidal Obstruction Syndrome Following Myeloablative Therapy and Tranexamic Acid Treatment for Hemorrhage in Two Patients with Neuroblastoma. Children (Basel) 2020;7:E198. [PMID: 33126407 DOI: 10.3390/children7110198] [Reference Citation Analysis]
106 Bonifazi F, Sica S, Angeletti A, Marktel S, Prete A, Iori AP, Olivari D, Rossetti G, Bertaina A, Botti S, Busca A, Carella AM, Cerretti R, Gargiulo G, Grassi A, Gualandi F, Irrera G, Milone G, Risitano AM, Santarone S, Vassallo E, Zecca M, Ciceri F, Pomponio G. Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group. Transplantation 2021;105:686-94. [PMID: 33273315 DOI: 10.1097/TP.0000000000003569] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Inagaki J, Noguchi M, Fukano R. Prognosis of pediatric patients with anicteric and late-onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Pediatr Blood Cancer 2020;67:e28412. [PMID: 32495502 DOI: 10.1002/pbc.28412] [Reference Citation Analysis]
108 Ragoonanan D, Khazal SJ, Wang J, Payne A, Kohorst M, Harden A, Tewari P, Petropoulos D, Shoberu B, Kebriaei P, Mahadeo KM, Tambaro FP. Improved detection of sinusoidal obstructive syndrome using pediatric-AYA diagnostic criteria and severity grading. Bone Marrow Transplant 2021;56:175-84. [PMID: 32665674 DOI: 10.1038/s41409-020-00998-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Lamble AJ, Tasian SK. Opportunities for immunotherapy in childhood acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2019;2019:218-25. [PMID: 31808843 DOI: 10.1182/hematology.2019000357] [Reference Citation Analysis]
110 Kim M, Rao S, Eickhoff JC, DeSantes KB, Capitini CM. A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation. J Pediatr Hematol Oncol 2020;42:145-8. [PMID: 30676436 DOI: 10.1097/MPH.0000000000001422] [Reference Citation Analysis]
111 Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, Falkenberg U, Bertaina A, Gibson B, Jarisch A, Balduzzi A, Boenig H, Krivan G, Vettenranta K, Matic T, Buechner J, Kalwak K, Lawitschka A, Yesilipek A, Lucchini G, Peters C, Turkiewicz D, Niinimäki R, Diesch T, Lehrnbecher T, Sedlacek P, Hutt D, Dalissier A, Wachowiak J, Yaniv I, Stein J, Yalçin K, Sisinni L, Deiana M, Ifversen M, Kuhlen M, Meisel R, Bakhtiar S, Cesaro S, Willasch A, Corbacioglu S, Bader P. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2020;55:1126-36. [PMID: 32029909 DOI: 10.1038/s41409-020-0818-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
112 Bahoush G, Vafapour M. A case report of severe veno-occlusive disease following autologous stem cell transplantation successfully treated with Defibrotide. Eur J Transl Myol 2020;30:9161. [PMID: 33117507 DOI: 10.4081/ejtm.2020.9161] [Reference Citation Analysis]
113 Roy Moulik N, Johnson I, Van Bruggen L, Petterson T, Mycroft J, Vaidya SJ. Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK. Pediatr Blood Cancer 2020;67:e28677. [PMID: 32865880 DOI: 10.1002/pbc.28677] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Xiao J, Tu J, Zhang H, Zhang F, Zhang W, Xu H, Yin Q, Yang J, Han H, Wang Y, Zhang B, Peng C, Zou X, Zhang M, Zhuge Y. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatol Int 2021;15:720-9. [PMID: 33507485 DOI: 10.1007/s12072-020-10126-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
115 Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, Lehmann L, Shore T, Ho VT, Bunin N, Iacobelli M, Liang W, Hume R, Tappe W, Soiffer R, Richardson P. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br J Haematol 2018;181:816-27. [PMID: 29767845 DOI: 10.1111/bjh.15267] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
116 Albers BK, Khanna G. Vascular Anomalies of the Pediatric Liver. Radiographics 2019;39:842-56. [PMID: 31059404 DOI: 10.1148/rg.2019180146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]